Olin (NYSE:OLN) Upgraded at KeyCorp

Olin (NYSE:OLN) was upgraded by research analysts at KeyCorp to a “strong-buy” rating in a note issued to investors on Thursday, Zacks reports. KeyCorp also issued estimates for Olin’s Q3 2026 earnings at $0.06 EPS, Q4 2026 earnings at ($0.20) EPS and FY2028 earnings at $1.35 EPS.

OLN has been the topic of a number of other reports. Citigroup lowered Olin from a “neutral” rating to an “underperform” rating in a research note on Tuesday, June 30th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $20.00 price objective (down from $25.00) on shares of Olin in a report on Monday, August 3rd. Royal Bank Of Canada cut their target price on shares of Olin from $24.00 to $20.00 and set a “sector perform” rating on the stock in a research report on Monday, August 3rd. Mizuho boosted their target price on shares of Olin from $23.00 to $24.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Bank of America downgraded shares of Olin from a “buy” rating to an “underperform” rating and dropped their price target for the company from $32.00 to $21.00 in a research note on Tuesday, June 30th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $22.62.

Olin Trading Down 1.1%

NYSE OLN opened at $17.27 on Thursday. The company has a quick ratio of 0.87, a current ratio of 1.42 and a debt-to-equity ratio of 1.77. Olin has a twelve month low of $16.73 and a twelve month high of $30.46. The company has a market cap of $1.97 billion, a price-to-earnings ratio of -14.04 and a beta of 1.20. The business’s fifty day moving average is $19.57 and its 200 day moving average is $23.56.

Olin (NYSE:OLN) last issued its quarterly earnings data on Thursday, July 30th. The specialty chemicals company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.25). Olin had a negative return on equity of 4.76% and a negative net margin of 2.08%.The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the firm earned ($0.01) EPS. The company’s revenue was down .9% on a year-over-year basis. As a group, sell-side analysts expect that Olin will post -0.68 EPS for the current fiscal year.

Hedge Funds Weigh In On Olin

A number of hedge funds and other institutional investors have recently made changes to their positions in OLN. Royal Bank of Canada lifted its position in shares of Olin by 20.2% in the 1st quarter. Royal Bank of Canada now owns 85,198 shares of the specialty chemicals company’s stock worth $2,066,000 after purchasing an additional 14,344 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Olin during the first quarter worth $32,000. Jones Financial Companies Lllp increased its position in shares of Olin by 467.9% during the first quarter. Jones Financial Companies Lllp now owns 13,805 shares of the specialty chemicals company’s stock worth $335,000 after buying an additional 11,374 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Olin by 57.6% during the first quarter. Goldman Sachs Group Inc. now owns 588,602 shares of the specialty chemicals company’s stock worth $14,268,000 after buying an additional 215,235 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Olin by 6.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 317,472 shares of the specialty chemicals company’s stock worth $7,696,000 after buying an additional 20,047 shares during the last quarter. 88.67% of the stock is owned by institutional investors and hedge funds.

Olin Company Profile

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.